Pharmabiz

Agenus appoints BAP Pharma as exclusive global partner for BOT+BAL access programmes

Agenus appoints BAP Pharma as exclusive global partner for BOT+BAL access programmes: Lexington, Massachusetts Thursday, April 23, 2026, 16:00 Hrs [IST] Agenus Inc., a leader in i ...
Pharmabiz

Genentech’s Enspryng reduces risk of relapses by 68%; shows potential to become first treatment for MOGAD

Genentech’s Enspryng reduces risk of relapses by 68%; shows potential to become first treatment for MOGAD: South San Francisco, California Thursday, April 23, 2026, 15:00 Hrs [I ...
Pharmabiz

HKeybio launches world's first NHP HS model with high clinical consistency to tackle global drug R&D bottleneck

HKeybio launches world's first NHP HS model with high clinical consistency to tackle global drug R&D bottleneck: Watertown, Massachusetts Thursday, April 23, 2026, 14:00 Hrs [IST] ...
Pharmabiz

Graviti Pharmaceuticals accelerates India expansion with Karnataka operations launch

Graviti Pharmaceuticals, a globally oriented pharmaceutical company with a strong and growing presence in international markets, has launched its operations in Karnataka. Building on the successful ...
Pharmabiz

Andelyn Biosciences and ENCell sign strategic partnership to expand global reach of gene therapy manufacturing

Andelyn Biosciences and ENCell sign strategic partnership to expand global reach of gene therapy manufacturing: Columbus, Ohio Thursday, April 23, 2026, 13:00 Hrs [IST] Andelyn Bi ...
Pharmabiz

DuPont launches Liveo Pharma TPE Overmolded Assemblies for pharma and biopharma applications

DuPont launches Liveo Pharma TPE Overmolded Assemblies for pharma and biopharma applications: Wilmington, Delaware Thursday, April 23, 2026, 12:00 Hrs [IST] DuPont announced the l ...
Pharmabiz

Sanofi provides update on the regulatory submission for Sarclisa subcutaneous in the US

Sanofi provides update on the regulatory submission for Sarclisa subcutaneous in the US: Paris Thursday, April 23, 2026, 11:00 Hrs [IST] The US Food and Drug Administration (FDA) ...
Pharmabiz

Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS

Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS: Basel Thursday, April 23, 2026, 10:00 Hrs [IST] Roche ann ...
Pharmabiz

Merck’s Idvynso, a new, two-drug single-tablet regimen of 100 mg doravirine and 0.25 mg islatravir gets US FDA approval for the treatment of HIV-1 infection

Merck’s Idvynso, a new, two-drug single-tablet regimen of 100 mg doravirine and 0.25 mg islatravir gets US FDA approval for the treatment of HIV-1 infection: Rahway, New Jersey ...
Pharmabiz

Illegal fertility injection racket in Badlapur sparks urgent call for statewide drug supply probe

The Maharashtra Food and Drug Administration (FDA) has been urged to investigate illegal fertility injection racket in Badlapur in Maharashtra which has also sparked an urgent call for a statewide ...
Pharmabiz

BDCDA issues advisory to trade fraternity on Mounjaro KwikPen batches which are suspected to be counterfeit

BDCDA issues advisory to trade fraternity on Mounjaro KwikPen batches which are suspected to be counterfeit: Nandita ...
Pharmabiz

C-CAMP with Imperial College London, to open Indo-UK Life Sciences Innovation Corridor for cooperation in biology research & entrepreneurship

Centre for Cellular and Molecular Platforms (C-CAMP) has signed an MoU with Imperial College London, to institute a ...